RBD-2080

N/A

Report date: 2025/04/11 14:45:46
NME

Base Information

Drug NameRBD-2080
Drug Alias NameRBD2080
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAsialoglycoprotein receptor modulators
TargetsAsialoglycoprotein receptor
Therapy Area/IndicationsNephrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryWorldMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Ribo Life Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Ribo Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsNephrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A